StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) income statement

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)

Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –

Lakefront Biotherapeutics NV income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
97.3%
Operating margin
26.5%
Net margin
28.9%
Return on equity, FY2025
–

Financial strength

Current ratio
20.15
Debt to equity
–
Debt to assets
–
Cash to current liabilities
57.5%

Valuation

P/E ratio
6.3
Price to sales
1.83
Price to book
–
Dividend yield
–

See a number that looks wrong?